Cwm, LLC Guardant Health, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cwm, LLC holds 385 shares of GH stock, worth $11,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares

385

Previous 404 4.7%

Holding current value

$11,811

Previous $12,000 25.0%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$22.3 - $36.29 $423 - $689	-19 Reduced 4.7%	385 $9,000
Q2 2024 Jul 09, 2024	SELL	$16.07 - $31.84 $353 - $700	-22 Reduced 5.16%	404 $12,000
Q1 2024 Apr 05, 2024	SELL	$17.13 - $26.91 $2,158 - $3,390	-126 Reduced 22.83%	426 $9,000
Q4 2023 Feb 01, 2024	SELL	$21.58 - $29.5 $9,322 - $12,744	-432 Reduced 43.9%	552 $15,000
Q3 2023 Oct 11, 2023	BUY	$25.8 - $39.97 $14,680 - $22,742	569 Added 137.11%	984 $29,000
Q2 2023 Aug 03, 2023	SELL	$20.94 - $38.01 $19,599 - $35,577	-936 Reduced 69.28%	415 $15,000
Q1 2023 Apr 28, 2023	SELL	$22.92 - $33.76 $2,612 - $3,848	-114 Reduced 7.78%	1,351 $32,000
Q4 2022 Feb 01, 2023	SELL	$25.44 - $59.78 $5,596 - $13,151	-220 Reduced 13.06%	1,465 $40,000
Q3 2022 Oct 27, 2022	SELL	$43.66 - $61.0 $2,139 - $2,989	-49 Reduced 2.83%	1,685 $91,000
Q2 2022 Jul 28, 2022	BUY	$28.82 - $77.35 $21,182 - $56,852	735 Added 73.57%	1,734 $70,000
Q1 2022 Apr 21, 2022	SELL	$48.25 - $100.49 $33,244 - $69,237	-689 Reduced 40.82%	999 $66,000
Q4 2021 Jan 31, 2022	SELL	$88.71 - $120.43 $4.47 Million - $6.07 Million	-50,421 Reduced 96.76%	1,688 $169,000
Q1 2021 Sep 15, 2021	BUY	$127.04 - $179.1 $331,574 - $467,451	2,610 Added 5.27%	52,109 $6.47 Million
Q1 2021 Apr 27, 2021	SELL	$127.04 - $179.1 $331,574 - $467,451	-2,610 Reduced 5.01%	49,499 $7.56 Million
Q4 2020 Sep 15, 2021	BUY	$99.96 - $135.93 $797,480 - $1.08 Million	7,978 Added 18.08%	52,109 $6.47 Million
Q4 2020 Jan 27, 2021	SELL	$99.96 - $135.93 $797,480 - $1.08 Million	-7,978 Reduced 15.31%	44,131 $5.69 Million
Q3 2020 Sep 15, 2021	BUY	$80.32 - $111.8 $1.52 Million - $2.11 Million	18,916 Added 56.99%	52,109 $6.47 Million
Q3 2020 Oct 19, 2020	SELL	$80.32 - $111.8 $1.52 Million - $2.11 Million	-18,916 Reduced 36.3%	33,193 $3.71 Million
Q2 2020 Sep 15, 2021	BUY	$60.49 - $97.5 $1.79 Million - $2.88 Million	29,523 Added 130.71%	52,109 $6.47 Million
Q2 2020 Jul 22, 2020	SELL	$60.49 - $97.5 $1.79 Million - $2.88 Million	-29,523 Reduced 56.66%	22,586 $1.83 Million
Q1 2020 Sep 15, 2021	BUY	$59.04 - $88.81 $3.08 Million - $4.63 Million	52,088 Added 248038.09%	52,109 $6.47 Million
Q1 2020 Apr 28, 2020	SELL	$59.04 - $88.81 $3.08 Million - $4.63 Million	-52,088 Reduced 99.96%	21 $1,000
Q4 2019 Sep 14, 2021	BUY	$59.49 - $82.78 $3.1 Million - $4.31 Million	52,088 Added 248038.09%	52,109 $6.47 Million
Q4 2019 Jan 27, 2020	SELL	$59.49 - $82.78 $3.1 Million - $4.31 Million	-52,088 Reduced 99.96%	21 $2,000
Q3 2019 Sep 14, 2021	BUY	$62.59 - $110.3 $3.26 Million - $5.75 Million	52,088 Added 248038.09%	52,109 $6.47 Million
Q3 2019 Oct 22, 2019	SELL	$62.59 - $110.3 $3.26 Million - $5.75 Million	-52,088 Reduced 99.96%	21 $1,000
Q2 2019 Sep 14, 2021	BUY	$63.94 - $91.11 $3.33 Million - $4.75 Million	52,088 Added 248038.09%	52,109 $6.47 Million
Q2 2019 Jul 31, 2019	SELL	$63.94 - $91.11 $3.33 Million - $4.75 Million	-52,088 Reduced 99.96%	21 $2,000
Q1 2019 Sep 02, 2021	BUY	$34.3 - $97.98 $1.79 Million - $5.1 Million	52,088 Added 248038.09%	52,109 $0
Q1 2019 Apr 22, 2019	BUY	$34.3 - $97.98 $240 - $685	7 Added 50.0%	21 $2,000
Q4 2018 Jan 25, 2019	BUY	$29.2 - $46.1 $408 - $645	14 New	14 $1,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.14B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account